Scientists are researching if a drug that’s being tested to treat a skin condition can also help keep COVID-19 patients off ventilators. The drug, labeled as EDP1815, was being tested on psoriasis patients, but Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, said it will now be tested on coronavirus patients who have pneumonia and inflammation of the lungs. To read the full article.
Recent Posts
- Majority of New Jerseyans Worried About Medical and Health Care Costs.
- NJACTS Community Engagement Core COVID-19 Resources
- With Drowning for Children on the Rise, a Rutgers Heath Expert Discusses Water Safety.
- Researcher Teams Up With Teen Champion Figure Skater to Discover Potential Treatments for Addiction Disorders.
- New Jersey Ranks Near the Bottom on Pay Equity for Mothers.
Categories
- Community (1,934)
- Covid (970)
- CTO Events (1)
- News (2,477)
- Pilots (20)